SOCW 6111 WK5Assgn_Mock_A
pdf
keyboard_arrow_up
School
Walden University *
*We aren’t endorsed by this school
Course
6111
Subject
Medicine
Date
Feb 20, 2024
Type
Pages
4
Uploaded by BailiffStarGuineaPig35
1
Adult Substance Use Assessment
Ashley Mock
Walden University
SOCW 6111: Advanced SW Practice I
Dr. Folusho Otuyelu
October 1, 2023
2
Adult Substance Use Assessment
Assessment Tool
I analyzed the Level 2—Substance Use—Adult (Adapted from the NIDA-Modified ASSIST) assessment tool (American Psychiatric Association n.d.). The tool includes 15 questions that examine prescription and illegal drug usage in adults (American Psychiatric Association, n.d.). Each question explores the intensity and frequency of the use of multiple different substances (American Psychiatric Association, n.d.). I chose this tool because I currently work with the substance use disorder (SUD) population and have not used this scale specifically.
Advantages and Limitations
This assessment tool possesses many advantages. Asking direct, closed-ended questions allows the clinician to observe reactions and explain anything the client may not understand. An interviewer can also immediately describe the findings to the participant for clarity and include the participant in determining if further intervention and referrals are needed. (USDA, 2018).
This screening tool can be utilized throughout treatment and at multiple appointments (American Psychiatric Association, n.d.). This allows clinicians to track progress over time. Continuous high scores may indicate substantial abuse and should be investigated, addressed, and monitored. (American Psychiatric Association, n.d.). The Level 2- Substance Abuse tool can enhance connections between primary healthcare providers and SUD treatment programs (National Institute on Drug Abuse, 2011).
This screening tool may also possess limitations. Self-screening tools may prevent the reporting of drug use due to stigma, fear, and legal consequences (Oga et al., 2020). The ASSIST is currently only validated for usage in interviews. More study is required to evaluate whether it
3
is acceptable for self-administration (USDA, 2018). Also, it is possible that clients may not have the trust and rapport with physicians to disclose this information. This assessment tool does not provide a diagnosis and may leave high-risk participants without the assessment they genuinely need (National Institute on Drug Abuse, 2011).
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
4
References
American Psychiatric Association. (n.d.). Online assessment measures
. https://www.psychiatry.org/psychiatrists/practice/dsm/educational-resources/assessment-
measures
National Institute on Drug Abuse. (2011). Screening for drug use in general medical settings
[PDF]. https://nida.nih.gov/sites/default/files/pdf/screening_qr.pdf
Oga, E. A., Mark, K., Peters, E. N., & Coleman-Cowger, V. H. (2020). Validation of the nida-
modified assist as a screening tool for prenatal drug use in an urban setting in the united states. Journal of Addiction Medicine
, 14
(5), 423–430. https://doi.org/10.1097/adm.0000000000000614
USDA. (2018). Substance use prevention: Screening, education, and referral resource guide for local wic agencies
[PDF]. https://wicworks.fns.usda.gov/sites/default/files/media/document/ResourceManual%20re
v%204-17-18.pdf